Getinge (GETI B.ST) Aktie Kurs
Getinge Kurs
Omsætningen er vokset med 5,3 % om året de seneste 19 år til 34,97 Mrd. SEK. Indtjening pr. aktie er vokset med 3,1 % om året de seneste 19 år. Getinges nettoavance ligger på 6,5 %, ned fra 11,0 % for flere år siden. Getinge har i øjeblikket et direkteafkast på omkring 1,69 %. Udlodningsandelen er omkring 55 % af indtjeningen. Udbyttet er vokset med 4,7 % om året de seneste 19 år. Analytikernes mediankursmål er 231,03 SEK, hvilket er under den aktuelle kurs med 15,0 %. Af 14 analytikere anbefaler 8 køb — den samlede vurdering er Køb.
Getinge aktiekurs
Hent disse data via Eulerpool API
100.000 requests/md. gratis · intet kreditkort
Getinge aktie og aktieanalyse
Hyppigt stillede spørgsmål om Getinge-aktien
Getinge AB is a global medical technology company that specializes in providing solutions for hospitals and healthcare organizations. The business model of Getinge AB revolves around offering innovative products, systems, and services within areas such as surgical workflows, patient care, and infection control. They strive to improve patient outcomes and enable healthcare professionals to deliver efficient and safe care. With a focus on providing high-quality medical equipment and integrated solutions, Getinge AB aims to enhance the overall healthcare experience.
Getinge AB is primarily active in the healthcare industry.
The main competitors of Getinge AB in the market include leading medical technology companies such as Medtronic, Johnson & Johnson, and Siemens Healthineers. These companies also provide a wide range of innovative medical devices and solutions, competing with Getinge AB in areas such as surgical equipment, patient handling systems, and infection control products. Getinge AB, as a global provider of medical technology, faces intense competition in its quest to deliver advanced healthcare solutions to customers worldwide.
Getinge AB, a renowned Swedish company, has a rich history and a strong background in the healthcare industry. Established in 1904, Getinge has evolved into a global leader in medical technology, providing innovative solutions for infection control and surgical workflows. With a primary focus on improving patient outcomes and enhancing healthcare efficiency, Getinge offers a wide range of products and services, including advanced medical equipment, such as surgical tables, anesthesia systems, and sterilization equipment. Over the years, Getinge has expanded its operations internationally, becoming a trusted partner for healthcare institutions worldwide. Through continuous innovation and dedication to healthcare excellence, Getinge AB has firmly established itself as a leading player in the global medical technology market.
Getinge AB has achieved several significant milestones throughout its history. One major accomplishment was the acquisition of Maquet in 2000, which expanded the company's portfolio and global reach. In 2006, Getinge AB successfully listed its shares on the Stockholm Stock Exchange, strengthening its position in the market. The company has also made substantial progress in research and development, introducing innovative medical technology solutions for healthcare professionals worldwide. Additionally, Getinge AB has focused on sustainability initiatives, committing to reducing its carbon footprint and promoting environmentally friendly practices. These milestones demonstrate Getinge AB's commitment to growth, innovation, and sustainability in the healthcare industry.
Getinge AB, a renowned global medical technology company based in Sweden, operates in multiple countries and regions worldwide. With a strong international presence, Getinge AB extends its operations across various continents, including Europe, Asia, North America, and Latin America. The company establishes its footprint in countries such as Sweden, Germany, France, the United States, China, Brazil, and many more. Through its extensive network and subsidiaries, Getinge AB serves customers across the globe, contributing to the advancement of healthcare and improving patient outcomes.
Getinge AB is committed to upholding certain values and corporate philosophy. The company believes in promoting patient safety and enhancing healthcare outcomes. They prioritize quality in their products and services, ensuring efficient and reliable medical solutions. Getinge AB strives for sustainability by minimizing the environmental impact of their operations and products. They value transparency, integrity, and accountability in their business practices. Getinge AB consistently focuses on innovation and advancement in the healthcare industry, aiming to improve patients' lives worldwide. With their dedication to their mission and values, Getinge AB continues to be a trusted and influential player in the medical technology sector.
Analytikere sætter i øjeblikket et gennemsnitligt kursmål på 238,81 SEK for Getinge-aktien (median: 231,03 SEK), svarende til -12,2 % i forhold til seneste kurs. Konsensus bygger på 14 analytikervurderinger.
14 analytikere vurderer i øjeblikket Getinge-aktien: 8 anbefaler køb, 5 hold og 1 salg. For 2026 forventer analytikere, at Getinge genererer omsætning på 35,26 Mrd. SEK og indtjening pr. aktie på 12,89 SEK.
Omregnet til den aktuelle valutakurs handles Getinge-aktien til 24,78 EUR (271,90 SEK).
Getinge-aktien (GETI B.ST) er noteret på 9 børser, herunder: London (0GZV.L), SIX (Zürich) (GETIB.SW), Frankfurt (GTN.F), München (GTN.MU), Düsseldorf (GTN.DU), Stockholm (GETI B.ST).
Getinge AB is a Swedish company specializing in the manufacturing of medical devices and solutions. The company operates in three main areas: Acute Care Therapies, Life Science, and Surgical Workflows. Getinge offers products and services to improve patient care and enhance the efficiency and profitability of hospitals and medical facilities. They provide solutions for critical care situations, infection prevention and control, as well as for the life sciences, pharmaceutical, and food industries. Getinge also offers products and solutions for surgical workflows, including cleaning, disinfection, sterilization, and training services. The company follows a value-based healthcare model, aiming to provide value to customers by ensuring optimal patient treatment and economic responsibility. With a focus on continuous innovation, Getinge strives to meet the evolving needs of its customers as a global leader in the medical technology industry.
forventet-omsætningen for Getinge er 35,26 Mrd. SEK. Dette tal er baseret på aktuelle finansielle data og afspejler virksomhedens forretningsydeevne.
forventet-overskuddet for Getinge er 3,51 Mrd. SEK. Nettooverskuddet afspejler virksomhedens rentabilitet efter fradrag af alle udgifter.
Pris-til-indtjening-forholdet (P/E) for Getinge er i øjeblikket 21,10. P/E-forholdet sammenligner den nuværende aktiekurs med indtjeningen pr. aktie og hjælper investorer med at vurdere værdiansættelsen af Getinge-aktien.
Pris-til-salgs-forholdet (P/S) for Getinge er i øjeblikket 2,10. P/S-forholdet sammenligner markedskapitalisering med årlig omsætning og fungerer som en værdiansættelsesmetrik for Getinge-aktien.
AlleAktien-kvalitetsscore for Getinge er 4/10.
ISIN for Getinge er SE0000202624. ISIN (International Securities Identification Number) er en globalt unik identifikator for værdipapirer.
WKN for Getinge er 889714. WKN (Wertpapierkennnummer) er et seks-cifret tysk identifikationsnummer for værdipapirer.
Tickeren for Getinge er GETI B.ST. Tickersymbolet bruges til at handle Getinge-aktier på børsen.
Getinge aktie
Getinge Peer Group
Getinge Ticker
Getinge FIGI
Alle fundamentale data om Getinge i deep dive
Vores aktieanalyse af Getinge-aktien indeholder vigtige finansielle nøgletal som omsætning, profit, P/E-ratioen, P/S-ratioen, EBIT samt informationer om udbytte. Desuden ser vi på aspekter som aktier, markedskapitalisering, gæld, egenkapital og forpligtelser hos Getinge. Hvis du søger mere detaljerede oplysninger om disse emner, tilbyder vi på vores undersider omfattende analyser: